T. Rowe Price Health Sciences has the expertise and structure it needs to add value in this rapidly evolving market segment, resulting in a Morningstar Analyst Rating of Silver.
NAV / 1-Day Return
92.42 / 0.48 %
Adj. Expense Ratio
Longest Manager Tenure
Investment StyleLarge Growth
Min. Initial Investment
Morningstar’s Fund Analysis PRHSX
Will PRHSX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.